Published in

American Heart Association, Stroke, suppl_1(32), p. 374-374, 2001

DOI: 10.1161/str.32.suppl_1.374

Links

Tools

Export citation

Search in Google Scholar

Intra-arterial therapy following intravenous alteplase for severe ischemic stroke

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

P190 Background Intravenous alteplase may not be efficacious for the majority of patients with proximal large vessel occlusion. Intra-arterial thrombolysis improves outcome in MCA occlusion but delays occur between the decision to proceed to interventional therapy and its application. Initial administration of intravenous alteplase prior to an intra-arterial approach may provide better outcomes due to earlier exposure of thrombus to alteplase and subsequently improved re-canalisation rates. Criteria for patient selection are undefined. Methods Case series with 90d outcomes. Between February 1999 and July 2000, 7 patients ranging in age from 40–84 years were treated with an IV/IA approach. All patients received IV alteplase within 3h of stroke onset. Two patients had basilar occlusions and six had MCA M1 stem or one or both M2 branch occlusions. Patients were selected using one or both of pre-treatment TCD examination (n=5) or large DWI/PWI mismatch with MRA documented occlusion (n=3). One patient with an MCA occlusion had severe vessel tortuosity and did not receive IA alteplase because access to the thrombus was not possible. Results The median NIHSS score was 19 (range 10–24). Intra-arterial therapy was started between 2–3h of symptom onset in all cases. Angiographic recanalisation was successful in all patients who had an intervention (6 of 7 patients). One patient underwent vertebral artery angioplasty instead of thrombolysis. Two patients died or were severely disabled (mRS 5–6), one from contralateral recurrent MCA stroke several days post-procedure and one with a severe basilar artery stroke. The remaining 4 patients with MCA occlusions had excellent neurological outcomes and were independent at 90d. There were no symptomatic hemorrhages. Conclusions Selection of patients for IV/IA therapy is aided by early cerebrovascular imaging. IV/IA therapy can be performed within 3h of stroke onset and can result in excellent outcomes for patients with the most severe of ischemic strokes.